Pharmacogenomics

Our research is focused on understanding how drugs work in the complex context of genetic heterogeneity, and the identification of novel drug targets for cancer therapy. To achieve this we employ various functional genomic screening and systems biology approaches.

The Pharmacogenomics group is led by Professor Sebastian Nijman